Table 1.
Characteristics of brain tumor survivors
| Survivors (N=78) |
||
|---|---|---|
| N | % | |
| Sex | ||
| Female | 36 | 46 |
| Male | 42 | 54 |
| Age at Diagnosis, years | ||
| <5 | 22 | 28.2 |
| 5-9 | 26 | 33.3 |
| 10-14 | 21 | 26.9 |
| 15-20 | 9 | 11.5 |
| Time since Diagnosis, years | ||
| 5-9 | 12 | 15.4 |
| 10-14 | 30 | 38.5 |
| 15-19 | 22 | 28.2 |
| >20 | 14 | 17.9 |
| Tumor Type | ||
| Astrocytic | 40 | 51.3 |
| Medulloblastoma | 13 | 16.7 |
| Ependymoma | 9 | 11.5 |
| Other | 16 | 20.5 |
| Extent of Surgery | ||
| None/or Biopsy Only | 18 | 23.1 |
| Partial/Near Total Resection | 24 | 30.8 |
| Gross Total Resection | 36 | 46.1 |
| Chemotherapy | ||
| Yes | 24 | 30.8 |
| No | 54 | 69.2 |
| Radiation | ||
| None | 26 | 33.3 |
| Cranial | 29 | 37.2 |
| Craniospinal | 23 | 29.5 |
|
|
||
| Median | Range | |
|
|
||
| Segment Specific Dose, cGya | ||
| Spine | 3600 | 2430-6050 |
| Posterior Fossa | 5070 | 0-7020 |
| Temporal Lobe | 5040 | 0-7200 |
| Frontal Cortex | 3520 | 0-6000 |
| Occipital/Parietal Lobe | 3520 | 0-7020 |
a
cGy indicates centigray. Includes dose and boost to tumor bed.